The Legal 500

UL. LITEWSKA 3/1, 60-605 POZNAN, POLAND
Tel:
Work +48 61 848 19 09
Fax:
Fax +48 61 848 15 39
Web:
www.sojka-maciak.com
Email:
Warsaw, Poznan

Przemysław Maciak

Tel:
Work +48 61 848 19 09
Email:
Sojka & Maciak Adwokaci SP.K.

Work Department

Pharmaceutical Law, Consumer Law, Cooperative Law, White Collar Crimes, Class actions.

Position

Managing Partner of Sójka & Maciak.

Career

He specialises in pharmaceutical law, with particluar emphasis on the issues regarding the introduction of a product to the market, obtaining the necessary authorizations, responsibility for the product, advertising of pharmaceuticals, as well as legal mechanisms of parallel import of medicinal products and marketing mechanisms with reference to regulated trading. Przemyslaw Maciak represents plaintiffs in unprecedented litigations against pharmaceutical concerns for responsibility for harms resulting from the application of medicinal products as well as harms resulting from the conduct of clinical trials. His business experience includes comprehensive counsel regarding the issue of currency options and negotiations with banks. Przemysław Maciak personally advised a great number of large join-stock companies during their negotiations with banks. As a result our Clients managed to restructure successfully and adopt suitable recovery proceedings. Przemysław Maciak is the Managing Partner with responsibility for the firm’s overall development strategy. He took an active part and also headed economic missions of Polish enterpreneurs to emerging markets (India 2010, Brasil 2009, 2011). He also coordinates the representation of the Clients in their most important lawsuits.

Languages

Przemysław Maciak knows English and French.

Member

He is a member of the District Bar Council in Poznań.

Education

Graduated from the Faculty of Law and Administration of Adam Mickiewicz University in Poznan. He was a scholar at Oxford University (1999) and the TMC Asser Institute in the Hague.

Back to index

Legal Developments in Poland

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to